Offshore renminbi funding costs in Hong Kong sink to record low
[HONG KONG] The cost to borrow the offshore renminbi in Hong Kong dropped to the lowest since data became available in 2013, putting pressure on the Chinese currency even as the US dollar weakens.
The one-month Hong Kong interbank offered rate for the renminbi – known as Hibor – dropped 11 basis points to 1.46 per cent, according to official data.
The record low rate is basically a sign of how easy it is for traders to source the Chinese currency in the city and allows them bet on further renminbi weakness. It comes amid expectations Beijing will keep liquidity ample to boost its economy and allow a managed renminbi depreciation to offset the impact of US tariffs.
The offshore renminbi slipped as much as 0.3 per cent on Tuesday (Apr 22) to around 7.31 per US dollar. It has recovered around 2 per cent from a record low hit this month.
Weakness in the greenback has lessened the need for the People's Bank of China to step in to steady the renminbi. Like many global peers, the currency has benefited from a global exodus from US assets that has weighed on the US dollar.
'The offshore renminbi's borrowing costs declined as the US dollar is too weak and there is no need for PBOC intervention to support the renminbi,' said Ju Wang, head of greater China FX & rates strategy at BNP Paribas. 'A loose funding situation offshore is also helpful for China to keep a weak renminbi to counter tariff risks, rather than a strong one.'
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Sign Up
Sign Up
Recent inflows from the mainland into Hong Kong's stock market have also helped to replenish the offshore renminbi's liquidity and pushed Hibor lower, according to Ken Cheung, chief Asia FX strategist at Mizuho Bank.
Mainland investors purchased a net HK$14.1 billion (S$2.4 billion) of these shares on Tuesday, set for the biggest daily amount in almost two weeks. They rushed to the offshore market this month to snap up tech shares and also due to some Hong Kong stocks' cheaper pricing compared with onshore peers.
The PBOC is seen allowing the renminbi to depreciate amid escalating trade tensions with the US. The Chinese central bank guided the currency lower by cutting its daily reference rate beyond a closely watched level this month, stoking bets Beijing may weaken the renminbi even further to counter some impacts of the tariffs.
'Cheap offshore renminbi funding cost corresponds with PBOC's recent onshore fixing guidance for moderate renminbi weakness,' said Fiona Lim, a senior foreign-exchange strategist at Malayan Banking. 'Drivers such as economic pressure at home, trade conflicts and broader US dollar weakness act as counterbalancing factors to keep renminbi somewhat stable.' BLOOMBERG

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Times
an hour ago
- Business Times
Chinese firms warn EU procurement curb could hurt trade ties
[BEIJING] A Chinese business lobby group warned that EU actions to curb access of the country's medical device makers to government contracts in the bloc will hurt trade ties. The China Chamber of Commerce to the EU expressed 'profound disappointment' over the EU's use of a trade tool to limit Chinese companies' participation in public procurements, according to a Monday (Jun 2) statement from the Chinese group. 'Its targeted application against Chinese enterprises sends a troubling signal-not only adding new complexity to China-EU economic and trade relations, but also contradicting the EU's stated principles of openness, fairness, and non-discrimination in market access,' said the organisation, whose members include the Bank of China, Cosco Shipping Holdings and BYD. The dispute threatens to add another irritant to relations just as Beijing seeks to shore up ties with the EU, positioning itself as a more reliable partner as US President Donald Trump alienates the bloc over issues from tariffs to defence. Chinese Commerce Minister Wang Wentao is due to meet with EU trade officials early this month in Paris, where he may address the bloc's trade grievances including a lack of fair access to China's own procurement market. European leaders will travel to Beijing for a summit next month with their Chinese counterparts. The EU curb represented the first use of its International Procurement Instrument, a 2022 law that's meant to promote reciprocity in access to public procurement markets. It allows the EU's executive arm to impose various restrictions on firms seeking to participate in procurements, ranging from score adjustments in tenders to an outright ban from contracts. The EU launched an investigation into China's procurement of medical devices last April, with the probe finding in January that Beijing discriminated against foreign firms. Consultations failed to find alternative solutions, Bloomberg previously reported. The Chinese commerce chamber argued that market reciprocity must be based on 'an accurate understanding of historical and practical realities'. 'For years, European medical device companies have enjoyed significant access to the Chinese market, playing a key role in supporting the modernisation of China's healthcare system and achieving substantial growth,' it said. 'The EU's current decision fails to acknowledge this context and undermines the spirit of balanced engagement and mutual benefit.' BLOOMBERG
Business Times
an hour ago
- Business Times
Asia: Markets rise as traders eye possible Trump-Xi talks
[HONG KONG] Asian stocks rallied on Tuesday as investors kept tabs on developments in the China-US trade war amid speculation the countries' leaders will hold talks soon. After a period of relative calm on the tariff front, Donald Trump at the weekend accused Beijing of violating last month's deal to slash huge tit-for-tat levies and threatened to double tolls on steel and aluminium. The moves jolted Asian markets on Monday, but hopes that the US president will speak with Chinese counterpart Xi Jinping - possibly this week - has given investors some hope for a positive outcome. Meanwhile, oil prices extended Monday's surge on a weak dollar and Ukraine's strike on Russian bombers parked deep inside the country that stoked geopolitical concerns as well as stuttering US-Iran nuclear talks. Trump has expressed confidence that a talk with Xi could ease trade tensions, even after his latest volley against the Asian superpower threatened their weeks-old tariff truce. 'They violated a big part of the agreement we made,' he said on Friday. 'But I'm sure that I'll speak to President Xi, and hopefully we'll work that out.' BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up It is unclear if Xi is keen on a conversation - the last known call between them was in the days before Trump's inauguration in January - but the US president's economic adviser Kevin Hassett signalled on Sunday that officials were anticipating something this week. US Treasury Secretary Scott Bessent - who last week warned negotiations with China were 'a bit stalled' - said at the weekend the leaders could speak 'very soon'. Officials from both sides are set for talks on the sidelines of an Organisation for Economic Co-operation and Development (OECD) ministerial meeting in Paris on Wednesday. While there has been no movement on the issue, investors took the opportunity on Tuesday to pick up recently sold shares. Hong Kong gained more than one per cent while Shanghai returned from a long weekend on the front foot. There were also gains in Tokyo, Sydney, Wellington, Singapore, Taipei and Manila. Seoul was closed for a presidential election. Deals queued up? The advances followed a positive day on Wall Street led by tech giants in the wake of a forecast-beating earnings report from chip titan Nvidia. Still, National Australia Bank's Rodrigo Catril remained nervous after Trump's latest salvos. 'The lift in tariffs is creating another layer of uncertainty and tension,' he wrote in a commentary. 'European articles suggest the lift in tariffs doesn't bode well for negotiations with the region (and) UK steelmakers call Trump doubling tariffs 'another body blow',' he added. 'The steel and aluminium tariffs also apply to Canada, so they will likely elicit some form of retaliation from there and while US-China trade negotiations are deteriorating due to rare earth, student visas and tech restrictions, steel tariffs will also affect China.' Separately, US Commerce Secretary Howard Lutnick on Monday voiced optimism for a trade deal with India 'in the not too distant future', adding that he was 'very optimistic'. And Japanese trade point man Ryosei Akazawa is eyeing another trip to Washington for more negotiations amid speculation of a deal as early as this month. Also in focus is Trump's signature 'big, beautiful bill' that is headlined by tax cuts slated to add up to US$3 trillion to the nation's debt. Senators have started weeks of what is certain to be fierce debate over the mammoth policy package, which partially covers an extension of Trump's 2017 tax relief through budget cuts projected to strip health care from millions of low-income Americans. Oil prices extended Monday's surge that saw West Texas Intermediate briefly jump five percent on concerns about an escalation of the Russia-Ukraine conflict and suggestions Washington could hit Moscow with stricter sanctions. That compounded news that the Opec+ producers' grouping had agreed a smaller-than-expected increase in crude production. Traders were also monitoring tensions over Iran's nuclear programme after Tehran said it would not accept an agreement that deprives it of what it calls 'peaceful activities'. AFP

Straits Times
2 hours ago
- Straits Times
Chinese firms warn EU procurement curb could hurt trade ties
The dispute threatens to add another irritant to relations between Beijing and the EU. PHOTO: REUTERS BEIJING – A Chinese business lobby group warned that EU actions to curb access of the country's medical device makers to government contracts in the bloc will hurt trade ties. The China Chamber of Commerce to the EU expressed 'profound disappointment' over the EU's use of a trade tool to limit Chinese companies' participation in public procurements, according to a statement from the Chinese group on June 2. 'Its targeted application against Chinese enterprises sends a troubling signal – not only adding new complexity to China-EU economic and trade relations, but also contradicting the EU's stated principles of openness, fairness, and non-discrimination in market access,' said the organisation, whose members include the Bank of China, Cosco Shipping Holdings and BYD. The dispute threatens to add another irritant to relations just as Beijing seeks to shore up ties with the EU, positioning itself as a more reliable partner as US President Donald Trump alienates the bloc over issues from tariffs to defence. Chinese Commerce Minister Wang Wentao is due to meet with EU trade officials early in June in Paris, where he may address the bloc's trade grievances, including a lack of fair access to China's own procurement market. European leaders will travel to Beijing for a summit in July with their Chinese counterparts. The EU curb represented the first use of its International Procurement Instrument, a 2022 law that's meant to promote reciprocity in access to public procurement markets. It allows the EU's executive arm to impose various restrictions on firms seeking to participate in procurements, ranging from score adjustments in tenders to an outright ban from contracts. The EU launched an investigation into China's procurement of medical devices in April 2024, with the probe finding in January that Beijing discriminated against foreign firms. Consultations failed to find alternative solutions, Bloomberg previously reported. The Chinese commerce chamber argued that market reciprocity must be based on 'an accurate understanding of historical and practical realities'. 'For years, European medical device companies have enjoyed significant access to the Chinese market, playing a key role in supporting the modernisation of China's healthcare system and achieving substantial growth,' it said. 'The EU's current decision fails to acknowledge this context and undermines the spirit of balanced engagement and mutual benefit.' BLOOMBERG Join ST's Telegram channel and get the latest breaking news delivered to you.